Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03112486 · ClinicalTrials.gov registry record
Out-of-hospital Cardiac Arrest (OHCA) Biomarkers
A clinical trial of Cardiac Arrest and Brain Injuries, sponsored by University of Florida.
- Completed
- Registry status
- 32
- Enrollment target
- 1
- Study location
NCT03112486: Completed study of Cardiac Arrest and Brain Injuries, sponsored by University of Florida.
NCT03112486 is a study of Cardiac Arrest and Brain Injuries that has completed, run by University of Florida. The registered enrollment target is 32 participants, below the 1,479-participant average among 31 other Cardiac Arrest trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03112486, a study of Cardiac Arrest and Brain Injuries, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
Few early prognostic indicators are currently available for patients' families and clinicians following out of hospital cardiac arrest (OHCA), and blood biomarkers may be of prognostic value in these cases. Brain tissue is highly dependent upon aerobic respiration, and oxygen deprivation result in irreversible neuronal cell injury. Peptides released into the blood by injured neuronal cells can be measured to estimate degree of injury, and potentially predict long term neurological outcome.
Primary Outcome
Higher blood biomarker levels will correlate with reduced rate of survival to hospital admission, survival to hospital discharge, and 6-month survival.
Conditions Studied
Interventions
- PROCEDURE blood draw
Study Locations (1)
Florida
- Univeristy of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2017-05-26 |
| Est. Completion | 2020-01-28 |
What the finished NCT03112486 record still lists
NCT03112486 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 1,479-participant average among 31 other Cardiac Arrest trials with a reported enrollment target (98% lower).
The record links to 9 conditions, with Cardiac Arrest appearing as the primary indexed condition, and to 1 intervention - of which blood draw is the first listed.
NCT03112486 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT03112486 about?
NCT03112486 is a clinical study titled "Out-of-hospital Cardiac Arrest (OHCA) Biomarkers". Few early prognostic indicators are currently available for patients' families and clinicians following out of hospital cardiac arrest (OHCA), and blood biomarkers may be of prognostic value in these cases. Brain tissue is highly dependent upon aerobic respiration, and oxygen deprivation result in i...
What is the current status of trial NCT03112486?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2017-05-26. Estimated completion is 2020-01-28.
What conditions does trial NCT03112486 study?
This clinical trial studies the following conditions: Cardiac Arrest, Brain Injuries, Cardiac Arrest, Out-Of-Hospital, Out-Of-Hospital Cardiac Arrest, Hypoxia-Ischemia, Brain.
What interventions are being tested in trial NCT03112486?
The interventions under investigation include: blood draw (PROCEDURE).
Who is sponsoring clinical trial NCT03112486?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03112486 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiac Arrest
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03112486's enrollment target sits among peer trials
32 24th of 31 higher than 8 of 31 other Cardiac Arrest trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiac Arrest trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Amiodarone in Shockable Cardiac Arrest
RECRUITING · Phase 3
-
Hospital Airway Resuscitation Trial
RECRUITING · NA
-
Post-CA Neuroprotection With Magnesium
RECRUITING · Phase 1
-
Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study
RECRUITING · NA
-
Resuscitative TEE Collaborative Registry
RECRUITING
-
Hydrogen's Feasibility and Safety as a Therapy in ECPR
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI